Vogenx Employee Directory

Vogenx corporate office is located in 3920 S Alston Ave, Durham, North Carolina, 27713, United States and has 1-10 employees.

Employees by Department

Departments

Number of employees

C-Suite

4

Engineering & Technical

2

Medical & Health

1

Finance

1

Vogenx CEO

James Green, Chief Executive Officer at Vogenx
United States flag for contact location.
James GreenChief Executive Officer
PhonePhoneEmailEmail
See Profile

Key Employees of Vogenx

  • Steven Delmar, Chief Financial Officer at Vogenx
    United States flag for contact location.
    Steven Delmar

    Chief Financial Officer

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

Vogenx Global Presence

globalPresence illustration
North America1-10

Index of contact profiles from Vogenx

Hundreds of professionals searching for Vogenx have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

People from Similar Companies in the Business Services Industry Located in North Carolina, United States

Frequently Asked Questions Regarding Vogenx Employees

How many employees does Vogenx have?
Vogenx has 1-10 employees
Who is the CEO of Vogenx?
Vogenx’s CEO is James Green
Who is the CFO of Vogenx?
Vogenx’s CFO is Steven Delmar
Who are Vogenx key employees?
Some of Vogenx key employees are Steven Delmar
Where is Vogenx located?
Vogenx’s headquarters are located at 3920 S Alston Ave, Durham, North Carolina, 27713, United States
How do I contact Vogenx?
Vogenx Contact Info: Phone number: (919) 659-5677 Website: www.vogenx.com
What does Vogenx do?

Vogenx, Inc. is a clinical-stage life science and drug development company headquartered in Durham, North Carolina. The company focuses on developing novel therapeutics for diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia, gastroparesis, and obesity. Its lead compound is a first-in-class, oral, small... molecule drug candidate (mizagliflozin) designed to inhibit postprandial glucose absorption and reduce excessive insulin and gastric inhibitory peptide secretion. Vogenx is dedicated to improving outcomes for patients suffering from serious metabolic and gastrointestinal conditions through innovative, science-driven treatment approaches.Read More

Is Vogenx a public company?
Vogenx is private company therefore does not currently have an official ticker symbol
See more information about Vogenx Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.